Erhardt A - Search Results

1

Response to antiviral treatment in patients infected with hepatitis B virus genotypes E-H.

Erhardt A, Göbel T, Ludwig A, Lau GK, Marcellin P, van Bömmel F, Heinzel-Pleines U, Adams O, Häussinger D. Erhardt A, et al. J Med Virol. 2009 Oct;81(10):1716-20. doi: 10.1002/jmv.21588. J Med Virol. 2009. PMID: 19697400

2

High prevalence of significant liver fibrosis and cirrhosis in chronic hepatitis B patients with normal ALT in central Europe.

Göbel T, Erhardt A, Herwig M, Poremba C, Baldus SE, Sagir A, Heinzel-Pleines U, Häussinger D. Göbel T, et al. Among authors: erhardt a. J Med Virol. 2011 Jun;83(6):968-73. doi: 10.1002/jmv.22048. J Med Virol. 2011. PMID: 21503908

3

Combination treatment of IFNalpha2b and ribavirin in patients with chronic hepatitis C and persistently normal ALTs.

Erhardt A, Behlen-Wilm U, Adams O, Donner A, Heintges T, Häussinger D. Erhardt A, et al. Dig Dis Sci. 2003 May;48(5):921-5. doi: 10.1023/a:1023051613300. Dig Dis Sci. 2003. PMID: 12772791 Clinical Trial.

4

SEN virus does not affect treatment response in hepatitis C virus coinfected patients but SEN virus response depends on SEN virus DNA concentration.

Sagir A, Adams O, Kirschberg O, Erhardt A, Heintges T, Haussinger D. Sagir A, et al. Among authors: erhardt a. World J Gastroenterol. 2004 Jul 1;10(13):1893-7. doi: 10.3748/wjg.v10.i13.1893. World J Gastroenterol. 2004. PMID: 15222031 Free PMC article.

5

Treatment of chronic hepatitis delta with pegylated interferon-alpha2b.

Erhardt A, Gerlich W, Starke C, Wend U, Donner A, Sagir A, Heintges T, Häussinger D. Erhardt A, et al. Liver Int. 2006 Sep;26(7):805-10. doi: 10.1111/j.1478-3231.2006.01279.x. Liver Int. 2006. PMID: 16911462 Clinical Trial.

6

Relapse to prior therapy is the most important factor for the retreatment response in patients with chronic hepatitis C virus infection.

Sagir A, Heintges T, Akyazi Z, Oette M, Erhardt A, Häussinger D. Sagir A, et al. Among authors: erhardt a. Liver Int. 2007 Sep;27(7):954-9. doi: 10.1111/j.1478-3231.2007.01508.x. Liver Int. 2007. PMID: 17696934

7

Long-term efficacy of tenofovir monotherapy for hepatitis B virus-monoinfected patients after failure of nucleoside/nucleotide analogues.

van Bömmel F, de Man RA, Wedemeyer H, Deterding K, Petersen J, Buggisch P, Erhardt A, Hüppe D, Stein K, Trojan J, Sarrazin C, Böcher WO, Spengler U, Wasmuth HE, Reinders JG, Möller B, Rhode P, Feucht HH, Wiedenmann B, Berg T. van Bömmel F, et al. Among authors: erhardt a. Hepatology. 2010 Jan;51(1):73-80. doi: 10.1002/hep.23246. Hepatology. 2010. PMID: 19998272

8

[Chronic hepatitis B with an unexpected coinfection].

Göbel T, Erhardt A, Richter J, Poremba C, Häussinger D. Göbel T, et al. Among authors: erhardt a. Med Klin (Munich). 2010 Nov;105(11):827-30. doi: 10.1007/s00063-010-1141-4. Epub 2010 Dec 7. Med Klin (Munich). 2010. PMID: 21136241 German.

9

Hepatitis C virus core protein induces cell proliferation and activates ERK, JNK, and p38 MAP kinases together with the MAP kinase phosphatase MKP-1 in a HepG2 Tet-Off cell line.

Erhardt A, Hassan M, Heintges T, Häussinger D. Erhardt A, et al. Virology. 2002 Jan 20;292(2):272-84. doi: 10.1006/viro.2001.1227. Virology. 2002. PMID: 11878930 Free article.

10

[Iron as comorbid factor in chronic hepatitis C].

Erhardt A, Hauck K, Häussinger D. Erhardt A, et al. Med Klin (Munich). 2003 Dec 15;98(12):685-91. doi: 10.1007/s00063-003-1314-5. Med Klin (Munich). 2003. PMID: 14685669 Review. German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

258 results

Search Page

Filters